These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

334 related items for PubMed ID: 22010782

  • 21. Development of orally disintegrating tablets of Perphenazine/hydroxypropyl-β-cyclodextrin inclusion complex.
    Wang L, Zeng F, Zong L.
    Pharm Dev Technol; 2013; 18(5):1101-10. PubMed ID: 22759202
    [Abstract] [Full Text] [Related]

  • 22. Preparation and characterization of simvastatin/hydroxypropyl-beta-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process.
    Jun SW, Kim MS, Kim JS, Park HJ, Lee S, Woo JS, Hwang SJ.
    Eur J Pharm Biopharm; 2007 Jun; 66(3):413-21. PubMed ID: 17240129
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Inclusion complexation of lorazepam with different cyclodextrins suitable for parenteral use.
    Holvoet C, Vander Heyden Y, Plaizier-Vercammen J.
    Drug Dev Ind Pharm; 2005 Jul; 31(6):567-75. PubMed ID: 16109630
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Effect of Methyl-β-Cyclodextrin on the antimicrobial activity of a new series of poorly water-soluble benzothiazoles.
    Trapani A, Catalano A, Carocci A, Carrieri A, Mercurio A, Rosato A, Mandracchia D, Tripodo G, Schiavone BIP, Franchini C, Mesto E, Schingaro E, Corbo F.
    Carbohydr Polym; 2019 Mar 01; 207():720-728. PubMed ID: 30600058
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Dramatic improvement of the solubility of pseudolaric acid B by cyclodextrin complexation: preparation, characterization and validation.
    Chi L, Liu R, Guo T, Wang M, Liao Z, Wu L, Li H, Wu D, Zhang J.
    Int J Pharm; 2015 Feb 20; 479(2):349-56. PubMed ID: 25575474
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Studies on the Preparation, Characterization, and Solubility of 2-HP-β-Cyclodextrin-Meclizine HCl Inclusion Complexes.
    George S, Vasudevan D.
    J Young Pharm; 2012 Oct 20; 4(4):220-7. PubMed ID: 23493156
    [Abstract] [Full Text] [Related]

  • 34. Studies on solubility and hypoglycemic activity of gliclazide beta-cyclodextrin-hydroxypropylmethylcellulose complexes.
    Aggarwal S, Singh PN, Mishra B.
    Pharmazie; 2002 Mar 20; 57(3):191-3. PubMed ID: 11933849
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Preparation, characterization and antimicrobial activity of inclusion complex of biochanin A with (2-hydroxypropyl)-β-cyclodextrin.
    Nikolic IL, Savic IM, Popsavin MM, Rakic SJ, Mihajilov-Krstev TM, Ristic IS, Eric SP, Savić-Gajic IM.
    J Pharm Pharmacol; 2018 Nov 20; 70(11):1485-1493. PubMed ID: 30168133
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.